Menopause Increases Risk of Relapse in Women with Schizophrenia
Menopause is a period of increased risk for women with schizophrenia spectrum disorders, and women are at higher risk for relapse than their age-matched male counterparts.
Menopause is a period of increased risk for women with schizophrenia spectrum disorders, and women are at higher risk for relapse than their age-matched male counterparts.
Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder. Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data regarding the reproductive safety of these medications.Â
Psychotic disorders such as schizophrenia and schizoaffective disorder are devastating disorders that usually require chronic care and impact individuals and their family members greatly in terms of morbidity and mortality. Research has helped to identify those who may be at greatest risk for developing psychotic disorders. Strategies to prevent psychotic disorders would alleviate suffering and have great public health significance.